In mid-October, Cardinal Health sent a voluntary medical device product correction letter concerning more than 3.9 million of its syringes because of the issue. As of Oct. 26, more than 16.6 million syringes have been added to the list, according to an FDA database.
The latest notice is classified as a Class I recall, the most serious type; using the product could lead to serious adverse events or death. The first 3.9 million syringes were classified as Class II.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
